HC Wainwright reissued their buy rating on shares of Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) in a report published on Wednesday, MarketBeat reports. HC Wainwright currently has a $14.00 price target on the stock. HC Wainwright also issued estimates for Evaxion Biotech A/S’s FY2024 earnings at ($0.01) EPS, FY2025 earnings at $0.13 EPS, FY2026 […]
Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) was upgraded by analysts at LADENBURG THALM/SH SH from a “neutral” rating to a “buy” rating in a report released on Tuesday, Briefing.com reports. The firm currently has a $8.00 target price on the stock. LADENBURG THALM/SH SH’s target price would suggest a potential upside of 143.16% […]
HC Wainwright began coverage on shares of Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) in a report published on Monday, MarketBeat reports. The brokerage issued a buy rating and a $14.00 price target on the stock. HC Wainwright also issued estimates for Evaxion Biotech A/S’s FY2023 earnings at ($6.90) EPS, FY2024 earnings at ($0.10) EPS, […]
Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) shares are going to reverse split on the morning of Monday, January 22nd. The 1-10 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the market closes on Monday, January 22nd. Evaxion Biotech A/S Price Performance NASDAQ:EVAX opened […]
Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.02), MarketWatch Earnings reports. Evaxion Biotech A/S Stock Performance Shares of NASDAQ EVAX opened at $0.67 on Thursday. Evaxion Biotech A/S has […]